|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 26002 |
FusionGeneSummary for PARK2_LANCL1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: PARK2_LANCL1 | Fusion gene ID: 26002 | Hgene | Tgene | Gene symbol | PARK2 | LANCL1 | Gene ID | 10314 |
| Gene name | LanC like 1 | ||
| Synonyms | GPR69A|p40 | ||
| Cytomap | 2q34 | ||
| Type of gene | protein-coding | ||
| Description | lanC-like protein 140 kDa erythrocyte membrane proteinG protein-coupled receptor 69ALanC (bacterial lantibiotic synthetase component C)-like 1LanC (bacterial lantibiotic synthetase component)LanC lantibiotic synthetase component C-like 1 | ||
| Modification date | 20180523 | ||
| UniProtAcc | O43813 | ||
| Ensembl transtripts involved in fusion gene | ENST00000366898, ENST00000366897, ENST00000366896, ENST00000366894, ENST00000338468, ENST00000366892, | ENST00000443314, ENST00000441020, ENST00000450366, ENST00000233714, ENST00000431941, | |
| Fusion gene scores | * DoF score | 4 X 2 X 3=24 | 5 X 3 X 5=75 |
| # samples | 4 | 5 | |
| ** MAII score | log2(4/24*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(5/75*10)=-0.584962500721156 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: PARK2 [Title/Abstract] AND LANCL1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | Tumor suppressor gene involved fusion gene, in-frame but not retained their domain. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |